晚期胃癌新药艾泽利®在京东健康全球首发

京东健康黑板报
Jan 15

1月15日上午,恒瑞医药自主研发的1类创新药瑞拉芙普α注射液(商品名:艾泽利®)在京东大药房连锁(江苏)有限公司苏州苏大附医店开出全球首单。瑞拉芙普α注射液是全球首款获批上市的抗PD-L1/TGF-βRII双特异性抗体融合蛋白,为晚期胃癌患者带来全新的治疗选择。作为“新特药全网首发第一站”,京东健康将持续发挥“超级医药供应链”优势能力,助力更多突破性疗法第一时间触达患者,推动创新治疗可及。我国晚期...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10